Several treatment methods have been determined exclusively for women with catamenial epilepsy.

None Catamenial pneumothorax is an extremely rare condition that affects women.

The exact cause of catamenial pneumothorax is unknown and several theories have been proposed.

Some women have a form of epilepsy called catamenial epilepsy.

Notably used on a short-term basis around menstruation in women with catamenial epilepsy.

Women with catamenial epilepsy are unusually sensitive to endogenous hormonal changes.

Estrogen can be found in the female body in various forms, all of which affect women with catamenial epilepsy.

The proper classification for catamenial epilepsy has been debatable for several decades.

Catamenial epilepsy is the term denoting seizures linked to the menstrual cycle.

Allopregnanolone may serve as an endogenous anticonvulsant and play a role in catamenial epilepsy.

Clobazam also has a useful role for very short-term seizure prophylaxis and in catamenial epilepsy.

Therefore, catamenial pneumothorax is probably under-recognised.

Catamenial epilepsy (CE) is when seizures cluster around certain phases of a woman's menstrual cycle.

By this measure, approximately one third of women with epilepsy would be classified under the designation of catamenial epilepsy.

Many women with epilepsy have more seizures in a pattern linked to the menstrual cycle; this is called "catamenial epilepsy".

Pleural implantations are associated with recurrent right pneumothoraces at times of menses, termed catamenial pneumothorax.

Women with catamenial pneumothorax have recurrent episodes of pneumothorax that occur within 72 hours before or after the start of menstruation.

During perimenopause, women with catamenial epilepsy generally experience an increase in seizure frequency, and HRT use does not change this likelihood.

Several studies following HRT use in women with catamenial epilepsy have demonstrated more influencable data than animal models, in this case.